REG - Cambridge Cognition - Director/PDMR Shareholding

Cambridge Cognition HoldingsAnnouncement

12/03/2019 17:25

RNS Number : 6573S
Cambridge Cognition Holdings PLC
12 March 2019
 


Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Director/PDMR Shareholdings
Further to the Fundraising announced on 7 March 2019, Cambridge Cognition Holdings plc, which develops and markets neuroscience technology to assess brain health, confirms the following disclosures by persons discharging managerial responsibilities.
The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.



1


Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")




a)


Name


Steven Powell




2.


Reason for the Notification




a)


Position/status


PDMR - Chief Executive Officer




b)


Initial notification/Amendment


Initial notification




3.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Cambridge Cognition Holdings Plc




b)


LEI


213800SZKDIN122EPA96




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


Ordinary Shares of 1 pence each




Identification code


GB00B8DV9647




b)


Nature of the transaction


Subscription for Ordinary Shares




c)


Price(s) and volume(s)





Price(s)


Volume(s)




72p


20,834








d)


Aggregated information:
·    Aggregated volume
 
·    Price


Subscription for 20,834 ordinary shares at a price of 72p each




e)


Date of the transaction


12 March 2019




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 



1


Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")




a)


Name


Nick Walters




2.


Reason for the Notification




a)


Position/status


PDMR - Chief Financial Officer




b)


Initial notification/Amendment


Initial notification




3.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Cambridge Cognition Holdings Plc




b)


LEI


213800SZKDIN122EPA96




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


Ordinary Shares of 1 pence each




Identification code


GB00B8DV9647




b)


Nature of the transaction


Subscription for Ordinary Shares




c)


Price(s) and volume(s)





Price(s)


Volume(s)




72p


13,889








d)


Aggregated information:
·    Aggregated volume
 
·    Price


Subscription for 13,889 ordinary shares at a price of 72p each




e)


Date of the transaction


12 March 2019




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 
Enquiries



Cambridge Cognition Holdings PLC
Steven Powell, Chief Executive Officer
Nick Walters, Chief Financial Officer
 


 
Tel: 01223 810 700
press@camcog.com




finnCap Ltd (NOMAD and Joint Broker)
Geoff Nash / Simon Hicks
Alice Lane / Manasa Patil
 


Tel: 020 7220 0500
(Corporate Finance)
(Corporate Broking)




Dowgate Capital Limited (Joint Broker)
David Poutney / James Serjeant
 


Tel: 020 3903 7715
 




IFC Advisory Ltd (Financial PR and IR)
Graham Herring / Miles Nolan / Zach Cohen


Tel: 020 3934 6630
 





About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.
 
For further information visit www.cambridgecognition.com 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDLLFFKXFLBBB